ASH 2022: Efficacy of Triplet Combinations in Acute Myeloid Leukemia
Posted: 02/01/2023 | By: Kayci Reyer

Two separate studies presented at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition—and highlighted in a report published in The ASCO Post—provide preliminary evidence that triplet combinations may have a role in the treatment of acute myeloid leukemia (AML).

Question 1 of 5

Two studies presented at the 2022 ASH Annual Meeting and Exposition found that triplet combinations—adding a third treatment to standard therapy anchored by ___—may be effective in patients with AML.

Choose 1